91132-18-2

Basic information

• Product Name: Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)- (9CI)
• Synonyms: Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)- (9CI)
• CAS NO: 91132-18-2
• Molecular Formula: C₁₁H₁₃NO
• Molecular Weight: 175.22702
• Product Categories: ISOPROPYL
• Mol File: 91132-18-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)- (9CI)(91132-18-2)
• EPA Substance Registry System: Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)- (9CI)(91132-18-2)

Safety Data

• Hazardous Substances Data: 91132-18-2(Hazardous Substances Data)

Upstream product

• 122-03-2 (4-isopropylbenzaldehyde) 
• 151-50-8 potassium cyanide 
• 824940-92-3 2-(4-isopropylphenyl)-2-((trimethylsilyl)oxy)acetonitrile 

Downstream Products

• 536-66-3 p-isopropylbenzoic acid 
• 122-03-2 (4-isopropylbenzaldehyde) 
• 66582-15-8 (4-Isopropyl-phenyl)-oxo-acetonitrile 
• 4607-63-0 4-isopropylmandelic acid 
• 3866-00-0 5-(4-isopropyl-phenyl)-4,5-dihydro-oxazol-2-ylamine 
• 91339-24-1 2-amino-1-(4-isopropylphenyl)ethanol 

Relevant articles and documents

Acceptorless and Base-free Dehydrogenation of Cyanohydrin with (η6-Arene)halide(Bidentate Phosphine)ruthenium(II) Complex

Ruthenium-catalyzed dehydrogenation of cyanohydrins under acceptorless and base-free conditions was demonstrated for the first time in the synthesis of acyl cyanide. As opposed to the thermodynamically preferred elimination of hydrogen cyanide, the dehydrogenation of cyanohydrins could be kinetically controlled with ruthenium (II) bidentate phosphine complexes. The effects of the arene, phosphine ligands and counter anions were investigated in regard to catalytic activity and selectivity. Selective dehydrogenation can occur via β-hydride elimination with the experimentally observed [(alkoxide)Ru] complex. (Figure presented.).

Amides for the treatment of atherosclerosis

This invention provides amide compounds as inhibitors of acyl-Coenzyme A: cholesterol O-acyltransferase (ACAT), pharmaceutical compositions containing such compounds, processes for the preparation of such compounds, and the use of such compounds as antihypercholesterolemic and/or antiatherosclerotic agents.